Advisory Services Network’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.86M | Buy |
77,940
+24,555
| +46% | +$1.16M | 0.04% | 505 |
|
|
2025
Q4 | $2.72M | Sell |
53,385
-45,465
| -46% | -$2.32M | 0.04% | 491 |
|
|
2025
Q3 | $5.49M | Buy |
98,850
+10,642
| +12% | +$623K | 0.08% | 259 |
|
|
2025
Q2 | $4.15M | Buy |
88,208
+34,747
| +65% | +$2.36M | 0.07% | 320 |
|
|
2025
Q1 | $3.71M | Sell |
53,461
-14,365
| -21% | -$1.19M | 0.07% | 314 |
|
|
2024
Q4 | $5.83M | Sell |
67,826
-27,260
| -29% | -$2.95M | 0.11% | 207 |
|
|
2024
Q3 | $13.6M | Hold |
95,086
| – | – | 0.28% | 67 |
|
|
2024
Q2 | $13.6M | Buy |
95,086
+11,573
| +14% | +$1.53M | 0.28% | 67 |
|
|
2024
Q1 | $10.7M | Buy |
83,513
+27,961
| +50% | +$3.33M | 0.24% | 84 |
|
|
2023
Q4 | $5.75M | Buy |
55,552
+18,708
| +51% | +$1.85M | 0.14% | 159 |
|
|
2023
Q3 | $3.35M | Sell |
36,844
-3,530
| -9% | -$311K | 0.09% | 256 |
|
|
2023
Q2 | $3.27M | Buy |
40,374
+750
| +2% | +$61.3K | 0.09% | 274 |
|
|
2023
Q1 | $3.15M | Buy |
39,624
+3,852
| +11% | +$273K | 0.09% | 273 |
|
|
2022
Q4 | $2.42M | Buy |
35,772
+3,934
| +12% | +$231K | 0.07% | 312 |
|
|
2022
Q3 | $1.59M | Buy |
31,838
+2,512
| +9% | +$135K | 0.06% | 396 |
|
|
2022
Q2 | $1.63M | Sell |
29,326
-540
| -2% | -$30K | 0.06% | 410 |
|
|
2022
Q1 | $1.66M | Sell |
29,866
-2,084
| -7% | -$107K | 0.05% | 454 |
|
|
2021
Q4 | $1.79M | Buy |
31,950
+3,514
| +12% | +$190K | 0.05% | 437 |
|
|
2021
Q3 | $1.36M | Sell |
28,436
-1,746
| -6% | -$84.4K | 0.04% | 491 |
|
|
2021
Q2 | $1.26M | Buy |
30,182
+2,680
| +10% | +$104K | 0.04% | 525 |
|
|
2021
Q1 | $927K | Buy |
27,502
+6,556
| +31% | +$234K | 0.03% | 576 |
|
|
2020
Q4 | $732K | Buy |
20,946
+12,044
| +135% | +$416K | 0.03% | 596 |
|
|
2020
Q3 | $309K | Buy |
8,902
+906
| +11% | +$30.2K | 0.01% | 815 |
|
|
2020
Q2 | $261K | Buy |
7,996
+1,296
| +19% | +$41.4K | 0.01% | 846 |
|
|
2020
Q1 | $201K | Sell |
6,700
-98
| -1% | -$2.92K | 0.01% | 816 |
|
|
2019
Q4 | $197K | Buy |
6,798
+940
| +16% | +$26K | 0.01% | 897 |
|
|
2019
Q3 | $149K | Hold |
5,858
| – | – | 0.01% | 917 |
|
|
2019
Q2 | $149K | Sell |
5,858
-8,290
| -59% | -$205K | 0.01% | 915 |
|
|
2019
Q1 | $370K | Buy |
14,148
+7,720
| +120% | +$190K | 0.03% | 600 |
|
|
2018
Q4 | $148K | Hold |
6,428
| – | – | 0.01% | 787 |
|
|
2018
Q3 | $151K | Sell |
6,428
-2
| -0% | -$49 | 0.01% | 837 |
|
|
2018
Q2 | $165K | Sell |
6,430
-8,896
| -58% | -$211K | 0.01% | 788 |
|
|
2018
Q1 | $377K | Buy |
15,326
+1,302
| +9% | +$34.2K | 0.03% | 592 |
|
|
2017
Q4 | $376K | Buy |
14,024
+1,472
| +12% | +$37.4K | 0.03% | 577 |
|
|
2017
Q3 | $302K | Sell |
12,552
-370
| -3% | -$8.36K | 0.03% | 528 |
|
|
2017
Q2 | $277K | Buy |
12,922
+5,520
| +75% | +$111K | 0.04% | 529 |
|
|
2017
Q1 | $127K | Buy |
+7,402
| New | +$129K | 0.02% | 741 |
|
|
2016
Q3 | $158K | Buy |
7,616
+3,140
| +70% | +$77.9K | 0.03% | 568 |
|
|
2016
Q2 | $120K | Buy |
4,476
+1,000
| +29% | +$27.4K | 0.03% | 566 |
|
|
2016
Q1 | $94K | Buy |
3,476
+676
| +24% | +$18.1K | 0.03% | 524 |
|
|
2015
Q4 | $81K | Hold |
2,800
| – | – | 0.03% | 486 |
|
|
2015
Q3 | $76K | Buy |
2,800
+758
| +37% | +$21.5K | 0.02% | 453 |
|
|
2015
Q2 | $57K | Buy |
2,042
+1,832
| +872% | +$51.5K | 0.02% | 481 |
|
|
2015
Q1 | $6K | Sell |
210
-24
| -10% | -$553 | ﹤0.01% | 956 |
|
|
2014
Q4 | $5K | Buy |
+234
| New | +$5.23K | ﹤0.01% | 900 |
|
|
2014
Q1 | – | Sell |
-420
| Closed | -$8K | – | 620 |
|
|
2013
Q4 | $8K | Buy |
+420
| New | +$7.32K | ﹤0.01% | 663 |
|
Other funds holding NVO
DAM
F
Advisory Services Network's NVO Position: Q1 2026 in Review
Advisory Services Network increased its Novo Nordisk (NVO) stake by 46% in Q1 2026, buying an estimated $1.16M and bringing the position to 77,940 shares worth $2.86M. The position accounts for 0.04% of the portfolio, ranked #505.
Advisory Services Network first reported a position in NVO in Q4 2013 and has held it in 46 quarters since. The position peaked at $13.6M in Q3 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Advisory Services Network held 77,940 shares of Novo Nordisk worth $2.86M as of Q1 2026.
- Advisory Services Network bought 24,555 Novo Nordisk shares in Q1 2026, an estimated $1.16M.
- Novo Nordisk made up 0.04% of Advisory Services Network's portfolio in Q1 2026, its #505 holding.
- Advisory Services Network first reported a position in Novo Nordisk in Q4 2013 and has held it in 46 quarters since.
- Advisory Services Network's Novo Nordisk position peaked at $13.6M in Q3 2024.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.